chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Information has been received from a consumer concerning her 26 year old daughter who is a respiratory therapist with allergy to theophylline, XOLAIR and one other medication that the mother could not remember name of, basal migraine, vocal cord dysfunction, possibly asthma and alpha-1 anti-trypsin deficiency who was vaccinated with a dose of PNEUMOVAX (Lot number unspecified). The mother thought that her daughter's first vaccination with PNEUMOVAX was on 01-Jan-2010 at 13:00 but she was not sure. Concomitant therapy included SYMBICORT, TOPAMAX and MSD. The patient's relevant past drug history included vaccinations against influenza virus A (antigen type unspecified) vaccine (H1N1) and regular influenza virus vaccine (unspecified) in approximately November 2009, about 2 months ago. The mother stated that on 01-Jan-2010 about 1 hour after vaccination, she began to experience behavioral changes, dizziness and passed out. The mother reports that her daughter described a feeling like she was coming out of her skin, and after that her feet start moving and her eyes rolled back. The patient also had some difficulty to breathing but she was not on a respirator. On 01-Jan-2010, she was admitted to an Intensive care unit at a local hospital and electroencephalography (EEG) was performed and the results were normal and a computed tomography (CAT scan) and the results was being performed at the time of reporting, results were not known. At the time of the report the patient was on oxygen and treated with albuterol (dose not reported) for her difficulty breathing. The patient continued to experience all of her symptoms. This was originally reported by a consumer. Additional information has been requested.
Per PCP report, client reports pain in left deltoid region with decreased shoulder range of motion since he received his Moderna vaccine on 3/25/2022.
Pain at the injection site; 99.5° - 100.6° fever; This spontaneous case was reported by a nurse (subsequently medically confirmed) and describes the occurrence of INJECTION SITE PAIN (Pain at the injection site) and PYREXIA (99.5° - 100.6° fever) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 015M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 22-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In February 2021, the patient experienced INJECTION SITE PAIN (Pain at the injection site) and PYREXIA (99.5° - 100.6° fever). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, INJECTION SITE PAIN (Pain at the injection site) and PYREXIA (99.5° - 100.6° fever) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medication was provided.
Patient was in to receive the Pfizer bivalent vaccine but was given the regular adult Pfizer in error.
I had headache that started at the right top of my head, I had double vision in my right eye.  I also had a black dot in my left eye.  I did go to St. Luke?s Hospital They did a CT scan and ruled out that there was nothing wrong with my brain.  I have been seeing a neurologist and they did an MRI.  They ruled out everything is normal.  I have headaches still, but they are not as frequent.
Right leg feeling numb above knee, back side of leg.  D/C'd home. Refused to be transported via ambulance to ER for evaluation and  treatment as indicated. D/C'd at 12:55 p.m.
1/1/2022 PT states that on 12/25 she had diarrhea, fatigue that lasted for 2 days.  This resolved after eating yogurt.  She subsequently started having body aches, throat pain, chest "burning" and SOA.    She was around her aunt on 12/24 who subsequently tested + for covid.    Patient states she has had ongoing symptoms though diarrhea, fatigue improved.  She subsequently started having shortness of air with some chest burning when she coughs.  No persistent chest pain other than with coughing.  Denies any documented fevers recently.  Has had some chills.   Denies any headache or neck pain.  1/1/2022- After discussion of patient's symptoms she did subsequently mention that she had some tingling in her right leg and right hand over the last 2 days.  This is not acutely changed states it has been improving.  She denies any focal weakness.  No speech or vision changes.  No trauma or injuries.  No recent neck injuries or neck manipulations.  No personal family history of aneurysms or brain bleeds. Review of Systems  Constitutional: Positive for fatigue (improved). Negative for chills and fever.  HENT: Positive for sore throat. Negative for congestion, nosebleeds, postnasal drip, rhinorrhea, sinus pressure, sinus pain and sneezing.   Eyes: Negative for pain and visual disturbance.  Respiratory: Positive for cough and shortness of breath.   Cardiovascular: Positive for chest pain. Negative for leg swelling.  Gastrointestinal: Positive for diarrhea (improved). Negative for abdominal pain, anal bleeding, blood in stool, nausea and vomiting.  Genitourinary: Negative for flank pain and vaginal bleeding.  Musculoskeletal: Positive for myalgias. Negative for arthralgias, back pain and neck pain.  Skin: Negative for rash.  Neurological: Negative for dizziness, syncope, speech difficulty, weakness, light-headedness, numbness and headaches.  All other systems reviewed and are negative.
Hives on legs and arms Pain in shoulders bilat, hips bilat, R wrist feeling generally weak
I started feeling nauseous on 04/09/21 and I broke out in shingles on 04/12/21. I started the anti-viral on 04/14/21 and ended that on 04/21/21. I still had swollen lymph nodes into May and according to my doctor it's because of the shingles, and the shingles lasted only a few days after taking anti-viral.
Mom presents toddler for evaluation of discrete papular rash on face only. No resides noted. Non pruitic. No other sings. Event approximately 6  weeks post vaccine. 10-15-02. 10-21-02 Parents report essentially no progression & rash dissipating.
This case was reported by a consumer via call center representative and described the occurrence of upset stomach in a 78-year-old male patient who received SHINGRIX for prophylaxis. Co-suspect products included escitalopram (LEXAPRO) for an unknown indication. On 12th February 2019, the patient received the 1st dose of SHINGRIX .5 ml. On 13th February 2019, the patient started LEXAPRO at an unknown dose and frequency. On 15th February 2019, 3 days after receiving SHINGRIX, the patient experienced upset stomach, nausea and chills. In February 2019, the patient experienced drug interaction. LEXAPRO was interrupted. On an unknown date, the outcome of the upset stomach, nausea and chills were not recovered/not resolved and the outcome of the drug interaction was unknown. It was unknown if the reporter considered the upset stomach, nausea and chills to be related to SHINGRIX. Additional details were provided as follows: On Tuesday, the patient received SHINGRIX in the upper part of left arm. The patient was not sure if the vaccine was administered intramuscularly. The patient did not feel it when it was administered. By Friday, the patient experienced an upset stomach, nausea and chills. The patient had taken LEXAPRO on Wednesday, Thursday and Friday so he called his physician who told him to stop the Lexapro in the event of a potential drug interaction. The patient had not taken LEXAPRO since Friday but he still had the same symptoms. On Monday, the patient saw his physician for the first time, so he did not see the need to provide his information. The patient did not consent to follow-up.
Swelling of face with itchyness that lasted for about 4 hours.  Bleeding at injection site that lasted for about an hour.  Pain from injection site to fingertips on and off for about 24 hours - mainly when heart rate was elevated.  Swelling at injection site of muscle was pronounced for about 48 hours.
Swollen hands a month after vaccines. Continued to the legs, knees, feet there after, now shoulders too. The inflammation has continued to increase pain on all my body and causing me to have a great deal of pain when sleeping and get stiffness when not moving.
A company representative reported that a child received an injection of Prevnar in 1/01. The next day, the child developed swollen eyes and was irritable, cranky, and "very" upset. No further information was available as of the date of this report.
Swollen lymph node in neck area, same side as injection.; This is a spontaneous report from a non-contactable consumer, the patient. A 25-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0150) via an unspecified route of administration in the left arm on 02Apr2021 (at the age of 25-years-old) as a single dose for COVID-19 immunisation. Other medical history not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications were not reported. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 08Apr2021, a week after first dose, the patient experienced swollen lymph node in neck area same side as injection and as of 18Apr2021, it was still swollen/present. The event resulted in doctor or other healthcare professional office/clinic visit. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event swollen lymph node in neck area was recovering at the time of this report.   No follow-up attempts are possible. No further information is expected.
Pt recvd vax & 2 months p/3rd dose exp elevated liver function test;
pt recv vax 21MAR96 & pt had severe hip pain on the rt,seen by MD;started pt on Indocin & resolved w/in 3 days;
Pt recvd 3 doses of Engerix-B 15FEB91, 15MAR91 & 18OCT91 & it was determined tha pt did not respond to the vax series; No tx was given; Reporter indicated that event was permanently disabling & "could interfere";
Patient was given 2 injections in right arm without any issues.  Patient passed out immediately after HPV shot was given in left arm.  She was laid down on table and convulsed for about 2 seconds.  Her lips turned white and she was out for about 30-45 seconds.  A wet towel was placed on forehead and she was able to communicate with us.  Patient sat up after a couple of minutes and was okay.  She admitted that she had not eaten since breakfast that morning.  She was walking around and talking without issue within minutes.
Head felt funny; Light headed; Had no energy, energy was diminished; Experienced a head rush; Felt dehydrated and had to drink a lot of water; Almost blacked out; Felt like her nervous system was affected/Felt shaky; became sensitive to caffeine; Chills; This spontaneous case was reported by a consumer and describes the occurrence of PRESYNCOPE (Almost blacked out), NERVOUSNESS (Felt like her nervous system was affected/Felt shaky), FEELING ABNORMAL (Head felt funny), DIZZINESS (Light headed) and ASTHENIA (Had no energy, energy was diminished) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Seizures (17years ago) and Brain tumor ((ben) 17years ago). Concurrent medical conditions included Drug allergy (Codiene) and Drug allergy (Keppra).    On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Feb-2021, the patient experienced NERVOUSNESS (Felt like her nervous system was affected/Felt shaky), CAFFEINE ALLERGY (became sensitive to caffeine) and CHILLS (Chills). On 27-Feb-2021, the patient experienced PRESYNCOPE (Almost blacked out), FEELING ABNORMAL (Head felt funny), DIZZINESS (Light headed), ASTHENIA (Had no energy, energy was diminished), VERTIGO (Experienced a head rush) and DEHYDRATION (Felt dehydrated and had to drink a lot of water). On 27-Feb-2021, PRESYNCOPE (Almost blacked out), FEELING ABNORMAL (Head felt funny), DIZZINESS (Light headed), ASTHENIA (Had no energy, energy was diminished), VERTIGO (Experienced a head rush) and DEHYDRATION (Felt dehydrated and had to drink a lot of water) had resolved. On 28-Feb-2021, NERVOUSNESS (Felt like her nervous system was affected/Felt shaky) and CHILLS (Chills) had resolved. At the time of the report, CAFFEINE ALLERGY (became sensitive to caffeine) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication information was not provided  Treatment information was not provided   This case was linked to MOD-2021-257112 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 14-Jul-2021: Follow up document received on 14-JUL-2021 contains: Updated Medical history of the patient- Seizures, Light headedness; Updated Second dose details;; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Within 12 hours of injection significant left foot swelling, left hand and left toe arthralgias was noted. Within 24 hours bilateral hand and toe arthralgias began and persisted, Within 48 hours bilateral knee pain started and other arthralgias persisted. Within one week spine arthralgias started. Two weeks post-vaccination chest discomfort began. Chest discomfort has subsided, but there is persistent bilateral hand, foot and knee arthralgias / swelling currently.
itch; This case was reported by a other health professional via interactive digital media and described the occurrence of pruritus in a adult patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, several months after receiving Shingles vaccine, the patient experienced pruritus. On an unknown date, the outcome of the pruritus was unknown.   It was unknown if the reporter considered the pruritus to be related to Shingles vaccine.  Additional details were reported as follows: The age at vaccination was not reported. The age group was not reported but was captured as adult as per vaccine indication. The patient experienced itching months after receiving vaccine
Swelling, redness, and itching of the right deltoid after receiving TDAP vaccine.
Information has been received from a certified medical assistant concerning a 12 month old male with no pertinent medical history or drug allergies, who on 15-MAY-2007 was vaccinated with a 0.5 mL SC dose of measles virus vaccine live (Enders-Edmonston) (+) mumps virus vaccine live (Jeryl Lynn) (+) rubella virus vaccine live (Wistar RA 27/3) (Lot#0381F). There was no concomitant medication. On approximately 17-MAY-2007, the patient developed a raised red bump at the injection site with described symptoms included being itchy, hard, and warm to the touch. No labs or diagnostic studies were performed. The patient was treated with topical antihistamine cream for the itch. Subsequently, the symptoms resolved and the patient recovered. Recently, the patient's mother noted a penny-size dimple at the injection site. There was no product quality complaint. This is one of several from the same source. Additional information has been requested.
This spontaneous report as received from a pharmacist refers to multiple patients of unknown age (anonymous, exact number of patients unspecified). On approximately 01-MAY-2013 (reported as a week ago) the patients were vaccinated subcutaneously with a dose of ZOSTAVAX (lot# not reported). On approximately 01-MAY-2013 (reported as a week ago) the patients experienced itching, water blisters around the injection site area, redness and swelling after receiving the ZOSTAVAX vaccine. Therapy was not reintroduced. All reactions cleared within 24 hours. The patient recovered in approximately May, 2013. This is one of several reports from same reporter. Additional information has been requested.
One week after the vaccine I was fine until I got to where I just couldn't hardly breathe. I went to the hospital and they admitted me and I had bronchitis and a touch of pneumonia. I've never had either one of those before. I was admitted into the hospital for 3 days. I had to take breathing treatments and antibiotics. I had never had either bronchitis or pneumonia in my life. I had a virtual visit with my PCP after I was discharged and I've had to just keep taking my breathing treatments and they put me on the hand puffers but after I got over all of that I was fine. It took me about two weeks to get over it.
p/vax pt awakened w/raised erythema area on lt deltoid;reported to medical squadron;area now 6cm x 6.5cm in size to see unit flight surgeon;
Headache, generalized aches-muscles, joint pain, fatigue, pain at site of injection.
First dose 1/13/21 second dose 2/1/21 Covid positive 4/19/21 symptoms stuffy nose/lose of taste and smell
This spontaneous report as received from a pharmacist refers to a patient of unknown age and gender. On 02-OCT-2014, the patient was vaccinated with expired dose of PNEUMOVAX 23, injection, 10 vials of 1, 0.5 ml, intramuscular (lot # J007059, expired date: 31-JUL-2014). Concomitant therapy was not reported. No adverse effects reported. Additional information has been requested.
Sore shoulder near injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Sore shoulder near injection site) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     The patient's past medical history included Injection site pain (Sore shoulder near injection site).    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On an unknown date, the patient experienced VACCINATION SITE PAIN (Sore shoulder near injection site). At the time of the report, VACCINATION SITE PAIN (Sore shoulder near injection site) outcome was unknown.            Reporter did not allow further contact
nausea around 9pm. sick with vomiting until 4am. diarrhea all night and the next day. the next night had a cough and congestion. not resolved as of today, 11/14/22
Low sats in the 80?s for 2.5 days, lost feeling in legs and feet, 104 fever for 4 days, muscles tightened and appeared like balls all over my body, lymph under arm was bigger than a baseball, vomiting for 3 days, full body aches, swollen eye.
Severe muscle pain in the shoulder joint, especially in the front/top of the joint, near the chest.
Chest pain - limited detail.  Evaluated as an outpatient.  Known rheumatology patient with chest pain.
R arm  pain and swelling at injection site starting about 24 hours after injection, still present 48 hours after injection Flushed feeling in face with headache starting about 33 hours after injection, lasting approximately 6 hours
Patient presented to emergency department on 7/20/2021 with generalized body aches, fatigue, and cough. She was found to be COVID-19 positive. She was treated with remdesivir, dexamethasone, and supplemental oxygen. Patient was discharged home on 7/31/2021.
Information has been received from a physician and an other health professional concerning a 2 year old male who on 03-Aug-2006 was vaccinated with a dose of measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live (+) varicella virus vaccine live (lot#654042/0663F).  On 03-Aug-2006 the patient experienced an injection site rash and out of the normal swelling.  Redness was also noted.  Subsequently, that recovered.  Medical attention was not sought.  No additional information is expected.
This case was reported by a nurse via sales rep and described the occurrence of injection site pain in a female patient who received BEXSERO. Co-suspect products included Meningococcal ACWY Vaccine (potential MENVEO). On an unknown date, the patient received BEXSERO and Meningococcal ACWY Vaccine (potential MENVEO) at an unknown dose. On an unknown date, unknown after receiving BEXSERO and Meningococcal ACWY Vaccine (potential MENVEO), the patient experienced injection site pain. On an unknown date, the outcome of the injection site pain was unknown. It was unknown if the reporter considered the injection site pain to be related to BEXSERO and Meningococcal ACWY Vaccine (potential MENVEO). Additional details were reported as follows: The age at vaccination was not reported. The reporter emailed a GlaxoSmithKline Sales representative who then emailed a GlaxoSmithKline Medical Science Liaison on the same day who contacted the GSK response center. It was reported that, the reporter had started giving BEXSERO along with the meningococcal vaccine (MCV4). The GlaxoSmithKline Medical Science Liaison said that, email from GlaxoSmithKline Sales representative stated that, the reporter said the reporter said that one of her daughters of unknown age had a sore arm at the injection site following vaccine administration. The GlaxoSmithKline Medical Science Liaison said that she spoke with the reporter but did not discuss about this patient and had no further related details to provide.
Bright red raised rash around injection site only on the arm, the left arm where injection was administered. Pain and numbness in left arm.
WRONG VACCINE ADMINISTERED; VACCINE ADMINISTERED WHERE VACCINE LEFT OUT FROM REFRIGERATOR FOR MORE THAN 6 HOURS; INAPPROPRIATE AGE AT VACCINE ADMINISTRATION; WRONG DOSE OF 0.3 ML INSTEAD OF 0.5 ML ADMINISTERED; This spontaneous report received from a patient concerned a 12 year old female. The patient's height, and weight were not reported. The patient's pre-existing medical conditions included patient had no known allergy. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, intramuscular, batch number: 0043A21A, and expiry: UNKNOWN) dose was not reported, administered on 10-JUN-2021 for prophylactic vaccination. No concomitant medications were reported.  On 10-JUN-2021, the subject experienced wrong vaccine administered. On 10-JUN-2021, the subject experienced vaccine administered where vaccine left out from refrigerator for more than 6 hours. On 10-JUN-2021, the subject experienced inappropriate age at vaccine administration. On 10-JUN-2021, the subject experienced wrong dose of 0.3 ml instead of 0.5 ml administered. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the wrong vaccine administered, wrong dose of 0.3 ml instead of 0.5 ml administered, inappropriate age at vaccine administration and vaccine administered where vaccine left out from refrigerator for more than 6 hours was not reported. This report was non-serious.